Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation.

Myeloma is the second most common hematological cancer, with 5800 cases per year diagnosed in the UK. Despite improved treatment it is still considered non-curable, although the median survival has...